AQP4 rs2339214: Sleep, Genetics, and Brain Amyloid-Beta
The rs2339214 variant is a specific genetic change located within the AQP4 gene. Research suggests this variant may moderate the relationship between sleep duration and the accumulation of amyloid-beta, a protein associated with Alzheimer's disease pathology.
What each genotype means
Typical amyloid-sleep association
This genotype represents the major allele homozygote for the rs2339214 variant. Research indicates that individuals with this profile do not exhibit the specific interaction where longer sleep duration is linked to increased amyloid-beta burden, a pattern observed in minor allele homozygotes.
This is the most common genotype in most studied populations, though exact frequencies vary by ancestry.
Typical amyloid-sleep association
This genotype represents the heterozygote state for the rs2339214 variant. Current research suggests that the specific interaction between longer sleep duration and higher amyloid-beta burden is primarily observed in individuals who are homozygous for the minor allele, rather than in heterozygotes.
This genotype is found at moderate frequencies across diverse global populations.
Modified amyloid-sleep association
This genotype represents the minor allele homozygote for the rs2339214 variant. Studies have shown that for individuals with this specific genotype, longer sleep duration is statistically associated with higher levels of brain amyloid-beta burden. This finding suggests that AQP4 genetic variation may influence the efficiency of the glymphatic system's clearance of brain metabolites during sleep.
This genotype is the least common of the three, with frequencies varying significantly depending on ancestral background.
Understanding the AQP4 Gene
The AQP4 gene encodes the aquaporin-4 protein, which is the most abundant water channel found in the human brain. Aquaporin-4 is primarily expressed by astrocytes, a type of support cell in the central nervous system. Its primary function is to regulate water homeostasis, ensuring that fluid balance within the brain remains stable. Beyond simple water transport, AQP4 is a critical component of the glymphatic system, a waste clearance pathway that helps remove metabolic byproducts from the brain's interstitial space. Because the glymphatic system is highly active during sleep, AQP4 is considered a key player in the brain's ability to clear proteins like amyloid-beta during rest. Disruptions in AQP4 expression or function are hypothesized to impair this clearance process, potentially contributing to the buildup of neurotoxic substances over time.
What is the rs2339214 Variant?
The rs2339214 variant is a single nucleotide polymorphism (SNP) situated within the AQP4 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. While most SNPs have no observable effect on health, some are studied for their potential to influence biological processes or disease risk. The rs2339214 variant has been identified in research as a factor that may interact with lifestyle behaviors, specifically sleep duration. Scientists investigate such variants to understand why individuals might have different physiological responses to the same environmental conditions. By studying this specific location on the genome, researchers aim to map how subtle genetic differences might influence the efficiency of the brain's waste clearance systems, particularly in the context of aging and neurodegenerative health.
Research and Evidence Strength
The evidence linking rs2339214 to brain health is currently classified as moderate and is primarily derived from observational studies. Research, such as that conducted within the Australian Imaging, Biomarkers and Lifestyle (AIBL) study, has examined how AQP4 variants interact with sleep parameters to influence amyloid-beta burden. Findings suggest that for individuals carrying specific alleles of rs2339214, the association between sleep duration and amyloid-beta levels may differ compared to those with other genotypes. Specifically, some data indicate that longer sleep duration might be linked to higher amyloid levels in minor allele homozygotes, a counterintuitive finding that highlights the complexity of these biological interactions. It is important to note that these studies are often cross-sectional, meaning they show an association at a single point in time rather than proving a direct cause-and-effect relationship. Further longitudinal research is required to confirm these findings.
Population Frequency and Interpretation
The frequency of the rs2339214 variant is variable across different global populations. Genetic databases indicate that the distribution of alleles can differ significantly depending on ancestral background, which is a common observation for many human genetic variants. Because the frequency is not uniform, the prevalence of specific genotypes will also fluctuate between ethnic and geographic groups. When interpreting this information, it is crucial to understand that genetic associations are statistical in nature and do not provide a diagnostic outcome for any individual. Having a particular genotype does not guarantee a specific health result, nor does it mean an individual will develop a disease. These findings are intended for educational purposes to help the public understand the ongoing research into the intersection of sleep, genetics, and brain health.
What You Can Do With This Information
Information regarding the rs2339214 variant is currently a subject of scientific inquiry and is not used in clinical practice to diagnose or predict Alzheimer's disease. If you are interested in your genetic profile, it is important to approach the data with the understanding that complex traits like brain health are influenced by a vast array of genetic, environmental, and lifestyle factors. You cannot use this information to make medical decisions or to alter your sleep habits without professional guidance. If you have concerns about your sleep quality, cognitive health, or family history of neurodegenerative conditions, the most effective step is to consult with a healthcare provider or a neurologist. They can provide personalized assessments based on clinical symptoms and established medical standards, rather than relying on individual genetic markers that are still being studied in research settings.
How common is this variant?
The frequency of the rs2339214 variant is variable across different global populations, with allele distributions differing significantly by ancestral background.
Frequently asked questions
Is rs2339214 a diagnostic test for Alzheimer's?
No, rs2339214 is not a diagnostic test. It is a genetic variant studied in research settings to understand biological mechanisms, and it cannot be used to predict or diagnose Alzheimer's disease in an individual.
Does this variant mean I should change how much I sleep?
No. You should not change your sleep habits based on this genetic information. Always consult with a healthcare professional regarding sleep concerns or any changes to your health routine.
What is the role of AQP4 in the brain?
AQP4 encodes a water channel protein that is essential for brain water homeostasis. It is a key component of the glymphatic system, which helps clear metabolic waste products from the brain.
Where can I find more information on AQP4 research?
You can find peer-reviewed research on AQP4 and its variants through databases like PubMed or the GWAS Catalog. These resources provide access to the latest scientific studies on the topic.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2339214?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in AQP4
This AQP4 variant moderates the effect of sleep latency on brain amyloid-beta burden and has been linked to altered trajectories of cognitive decline.
This Aquaporin-4 variant is associated with poorer overall sleep quality and moderates the relationship between sleep duration and brain amyloid-beta burden.
This variant in the AQP4 gene is associated with the moderation of sleep latency effects on brain amyloid-beta and is implicated in cognitive decline trajectories.